# Phase I Study in Patients With Solid Tumours

> **NCT00496028** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 148 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** AZD0530
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00496028
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-01
- **Final completion:** 2010-03
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2010-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496028, "Phase I Study in Patients With Solid Tumours". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00496028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*